NCT06691594 2025-02-20Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and ChemotherapyCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting20 enrolled